News Features Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019 L.A. McKeown December 12, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2019 Shelley Wood November 29, 2019
News Conference News AHA 2019 More Adverse Events, Higher Costs With Impella: New Observational Studies Caitlin E. Cox November 17, 2019
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Daily News Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD Michael O'Riordan November 05, 2019
News Conference News TCT 2019 Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT Michael O'Riordan September 27, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Two: Transcatheter Valves, New and Old Shelley Wood September 27, 2019
Presentation TCT 2019 TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT Presenter: Fabian Nietlispach September 26, 2019
News Daily News Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS Caitlin E. Cox September 20, 2019
News Conference News ESC 2019 Stopped Early, DAPA Offers Insight on ICD Timing After STEMI Shelley Wood September 04, 2019
News Conference News ESC 2019 New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises Michael O'Riordan September 04, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019
News Daily News Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II Caitlin E. Cox August 27, 2019
News Daily News Burst Balloons With Sapien 3 Ultra Prompt ‘Urgent Field Safety Notice’ and Canadian Recall Shelley Wood July 22, 2019
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019
News Conference News EAS 2019 Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role Michael O'Riordan June 07, 2019
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019